Abstract: Provided herein is an isolated antibody or antigen-binding fragment that specifically binds tau, the antibody or fragment comprising a heavy chain variable (VH) region and a light chain variable (VL) region having amino acid sequences set forth herein. Also provided are methods of preventing or treating a tauopathy in a subject, comprising administering to a human in need of therapy for a tauopathy with one or more antibodies or fragments as described herein, wherein the antibodies or antigen-binding fragment are administered under conditions and in an amount effective to prevent or treat the tauopathy.
Type:
Grant
Filed:
September 6, 2016
Date of Patent:
May 1, 2018
Assignee:
C2N Diagnostics, LLC
Inventors:
Tim West, Diljeet S. Athwal, Timothy D. Jones, Francis J. Carr, Robert George Edward Holgate